Lexiscan Injection, Solution
Product Images NDC 0469-6501

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lexiscan (NDC 0469-6501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure of regadenoson, the active ingredient in LEXISCAN injection solution, 0.08 mg/mL. The diagram shows the molecular arrangement including rings and functional groups with an associated water molecule.*

FDA Label Image

Lexiscan (regadenoson) Injection 0.4 mg/5 mL Label (Image 02)

Packaging label for Lexiscan (regadenoson) injection, 0.4 mg/5 mL (0.08 mg/mL) solution for intravenous use. The label shows a single-dose pre-filled syringe, marked as a pharmacologic stress agent for diagnostic purposes only. The product is sterile, nonpyrogenic, preservative-free, and for Rx only. Manufacturer is Astellas Pharma US, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.